MAPT and Alzheimer disease: With the K18 (4R) substrate, the specific seeding activity expressed as lag phase per ng of frontal cortex-derived tau demonstrated differences between rapidly and slowly progressive AD cases (Fig 3B) we observed previously with hippocampal cortex tau [3].